全文获取类型
收费全文 | 32975篇 |
免费 | 1896篇 |
国内免费 | 183篇 |
专业分类
耳鼻咽喉 | 314篇 |
儿科学 | 448篇 |
妇产科学 | 357篇 |
基础医学 | 4389篇 |
口腔科学 | 1000篇 |
临床医学 | 2126篇 |
内科学 | 7987篇 |
皮肤病学 | 862篇 |
神经病学 | 2297篇 |
特种医学 | 1280篇 |
外科学 | 5816篇 |
综合类 | 157篇 |
一般理论 | 1篇 |
预防医学 | 1030篇 |
眼科学 | 693篇 |
药学 | 2522篇 |
中国医学 | 51篇 |
肿瘤学 | 3724篇 |
出版年
2023年 | 139篇 |
2021年 | 584篇 |
2020年 | 360篇 |
2019年 | 440篇 |
2018年 | 566篇 |
2017年 | 514篇 |
2016年 | 572篇 |
2015年 | 596篇 |
2014年 | 791篇 |
2013年 | 988篇 |
2012年 | 1454篇 |
2011年 | 1614篇 |
2010年 | 920篇 |
2009年 | 832篇 |
2008年 | 1397篇 |
2007年 | 1403篇 |
2006年 | 1417篇 |
2005年 | 1503篇 |
2004年 | 1418篇 |
2003年 | 1425篇 |
2002年 | 1358篇 |
2001年 | 1308篇 |
2000年 | 1344篇 |
1999年 | 1219篇 |
1998年 | 420篇 |
1997年 | 347篇 |
1996年 | 321篇 |
1995年 | 293篇 |
1994年 | 255篇 |
1993年 | 240篇 |
1992年 | 821篇 |
1991年 | 727篇 |
1990年 | 735篇 |
1989年 | 699篇 |
1988年 | 712篇 |
1987年 | 623篇 |
1986年 | 613篇 |
1985年 | 598篇 |
1984年 | 391篇 |
1983年 | 324篇 |
1982年 | 148篇 |
1981年 | 133篇 |
1979年 | 318篇 |
1978年 | 203篇 |
1977年 | 151篇 |
1975年 | 149篇 |
1974年 | 213篇 |
1973年 | 151篇 |
1972年 | 165篇 |
1971年 | 147篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献
2.
3.
4.
5.
Atsushi Hata Takahiro Nakajima Keisuke Matsusaka Masaki Fukuyo Junichi Morimoto Takayoshi Yamamoto Yuichi Sakairi Bahityar Rahmutulla Satoshi Ota Hironobu Wada Hidemi Suzuki Hisahiro Matsubara Ichiro Yoshino Atsushi Kaneda 《International journal of cancer. Journal international du cancer》2020,146(2):388-399
6.
Takashi Murakami Naoto Sakamoto Akihito Nagahara 《Journal of gastroenterology and hepatology》2019,34(10):1685-1695
Sessile serrated adenoma/polyps (SSA/Ps) are early precursor lesions in the serrated neoplasia pathway, which results in BRAF‐mutated colorectal carcinomas with not only high levels of microsatellite instability but also microsatellite stable. SSA/Ps with advanced histology, including cytological dysplasia or minimally invasive carcinomas, are important lesions because SSA/Ps are considered major contributors to “interval cancers” and these lesions can rapidly become dysplastic or invasive carcinomas. Clinicopathologically, SSA/Ps with dysplasia or invasive carcinoma were associated with advanced age, female sex, and proximal colon. Although SSA/Ps with submucosal invasive carcinoma were smaller and invaded less deeply into the submucosal layer than conventional tubular adenomas with submucosal invasive carcinoma, SSA/Ps with submucosal invasive carcinoma frequently had a mucinous component and exhibited a higher potential for lymphatic invasion and lymph node metastasis. In an SSA/P series, endoscopic characteristics, including (semi)pedunculated morphology, double elevation, central depression, and reddishness, may help accurately diagnose SSA/Ps with advanced histology. Removal of SSA/Ps with dysplasia or invasive carcinoma was recommended. Endoscopic treatment such as endoscopic mucosal resection or endoscopic submucosal dissection is useful for those lesions. However, surgical resection with lymph node dissection might be indicated when SSA/Ps with invasive carcinoma are endoscopically suspected, because these have the high risk of lymph node metastasis. Greater awareness may promote further research into improving the detection, recognition, and complete resection rates of SSA/Ps with dysplasia or invasive carcinoma and reduce the interval cancer rates. 相似文献
7.
8.
9.
Higuchi Takashi Sugisawa Norihiko Yamamoto Jun Oshiro Hiromichi Han Qinghong Yamamoto Norio Hayashi Katsuhiro Kimura Hiroaki Miwa Shinji Igarashi Kentaro Tan Yuying Kuchipudi Shreya Bouvet Michael Singh Shree Ram Tsuchiya Hiroyuki Hoffman Robert M. 《Cancer chemotherapy and pharmacology》2020,85(2):285-291
Cancer Chemotherapy and Pharmacology - Cancers are methionine (MET) and methylation addicted, causing them to be highly sensitive to MET restriction. The present study determined the efficacy of... 相似文献
10.
Eitaro Ito Akihiro Takai Yoshinori Imai Hiromi Otani Yoshihiro Onishi Yosuke Yamamoto Kohei Ogawa Taiji Tohyama Shunichi Fukuhara Yasutsugu Takada 《Surgery》2019,165(2):353-359